{"transactions":[{"id":823169,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":2130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement."}],"balance_after":4258,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2130},"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":823168,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":1117,"derivative":{"underlying":"Ordinary Shares","underlying_shares":558},"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":823167,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."}],"balance_after":325,"derivative":{"underlying":"Ordinary Shares","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":823166,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":171},"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":823165,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1370,"price":61.27,"value":83939.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":10755,"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":823164,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2026-04-01T17:20:24.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":true,"shares":3184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001639691-26-000026","document":"wk-form4_1775078421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000026/wk-form4_1775078421.xml","form_type":"4"}},{"id":844272,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Stock Appreciation Rights","published_at":"2026-03-13T17:25:31.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date."}],"balance_after":0,"derivative":{"exercise_price":57.6,"expiration_date":"2026-03-11","underlying":"Ordinary Shares","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001639691-26-000015","document":"wk-form4_1773437128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000015/wk-form4_1773437128.xml","form_type":"4"}},{"id":844271,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2026-03-13T17:25:31.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":69,"price":62.26,"value":4295.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":8941,"source":{"system":"sec-edgar","filing":"0001639691-26-000015","document":"wk-form4_1773437128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000015/wk-form4_1773437128.xml","form_type":"4"}},{"id":844270,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2026-03-13T17:25:31.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1980,"price":62.26,"value":123274.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for stock appreciation right (\"SAR\") base price settlement."}],"balance_after":9010,"source":{"system":"sec-edgar","filing":"0001639691-26-000015","document":"wk-form4_1773437128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000015/wk-form4_1773437128.xml","form_type":"4"}},{"id":844269,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2026-03-13T17:25:31.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2140,"price":57.6,"value":123264.0,"ownership":{"direct":true},"balance_after":10990,"source":{"system":"sec-edgar","filing":"0001639691-26-000015","document":"wk-form4_1773437128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969126000015/wk-form4_1773437128.xml","form_type":"4"}},{"id":965507,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-12-17T16:06:29.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the \"Plan\") and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture\nprior to vesting in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the final vesting for which occurred on December 15, 2025. The RSUs were subject to forfeiture\nprior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":967},"source":{"system":"sec-edgar","filing":"0001639691-25-000163","document":"wk-form4_1766005586.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000163/wk-form4_1766005586.xml","form_type":"4"}},{"id":965506,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-12-17T16:06:29.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":416,"price":63.06,"value":26232.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":8850,"source":{"system":"sec-edgar","filing":"0001639691-25-000163","document":"wk-form4_1766005586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000163/wk-form4_1766005586.xml","form_type":"4"}},{"id":965505,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-12-17T16:06:29.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (\"RSUs\") settled in ordinary shares of LivaNova PLC (the \"Company\"), GBP 1.00 par value."}],"balance_after":9266,"source":{"system":"sec-edgar","filing":"0001639691-25-000163","document":"wk-form4_1766005586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000163/wk-form4_1766005586.xml","form_type":"4"}},{"id":1038200,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-09-17T16:05:35.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":false,"shares":643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the \"Plan\") and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments. The first vesting occurred on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":1932,"derivative":{"underlying":"Ordinary Shares","underlying_shares":643},"source":{"system":"sec-edgar","filing":"0001639691-25-000135","document":"wk-form4_1758139532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000135/wk-form4_1758139532.xml","form_type":"4"}},{"id":1038199,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-09-17T16:05:35.000Z","date":"2025-09-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":277,"price":55.43,"value":15354.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":8299,"source":{"system":"sec-edgar","filing":"0001639691-25-000135","document":"wk-form4_1758139532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000135/wk-form4_1758139532.xml","form_type":"4"}},{"id":1038198,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-09-17T16:05:35.000Z","date":"2025-09-15","kind":"exercise","planned":false,"acquired":true,"shares":643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (\"RSUs\") settled in ordinary shares of LivaNova PLC (the \"Company\"), GBP 1.00 par value."}],"balance_after":8576,"source":{"system":"sec-edgar","filing":"0001639691-25-000135","document":"wk-form4_1758139532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000135/wk-form4_1758139532.xml","form_type":"4"}},{"id":1186766,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Stock Appreciation Rights","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":13986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":13986,"derivative":{"exercise_price":39.13,"expiration_date":"2035-03-30","underlying":"Ordinary Shares","underlying_shares":13986},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186765,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":6388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":6388,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6388},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186764,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":3194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":3194,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3194},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186763,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":3194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":3194,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3194},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186762,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":6388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":6388,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6388},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186761,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":1675,"derivative":{"underlying":"Ordinary Shares","underlying_shares":559},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186760,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":650,"derivative":{"underlying":"Ordinary Shares","underlying_shares":325},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186759,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and\nthe award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":171,"derivative":{"underlying":"Ordinary Shares","underlying_shares":172},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186758,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and\nthe award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186757,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":542,"price":39.13,"value":21208.46,"ownership":{"direct":true},"balance_after":7933,"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1186756,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2025-04-01T21:00:26.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":true,"shares":1257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":8475,"source":{"system":"sec-edgar","filing":"0001639691-25-000023","document":"wk-form4_1743555619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969125000023/wk-form4_1743555619.xml","form_type":"4"}},{"id":1329346,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2024-12-17T17:23:02.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the\n\"Plan\") and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture\nprior to vesting in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On December 15, 2023, reporting person was granted RSUs subject to a two-year vesting schedule, the first vesting for which occurred on December 15, 2024. The RSUs are subject to forfeiture\nprior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":967,"derivative":{"underlying":"Ordinary Shares","underlying_shares":967},"source":{"system":"sec-edgar","filing":"0001639691-24-000150","document":"wk-form4_1734474176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000150/wk-form4_1734474176.xml","form_type":"4"}},{"id":1329345,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2024-12-17T17:23:02.000Z","date":"2024-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":416,"price":51.5,"value":21424.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":7218,"source":{"system":"sec-edgar","filing":"0001639691-24-000150","document":"wk-form4_1734474176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000150/wk-form4_1734474176.xml","form_type":"4"}},{"id":1329344,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Ordinary Shares","published_at":"2024-12-17T17:23:02.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":true,"shares":967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (\"RSUs\") settled in ordinary shares of LivaNova PLC (the \"Company\"), GBP 1.00 par value."}],"balance_after":7634,"source":{"system":"sec-edgar","filing":"0001639691-24-000150","document":"wk-form4_1734474176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000150/wk-form4_1734474176.xml","form_type":"4"}},{"id":1405500,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Stock Appreciation Rights","published_at":"2024-09-17T16:05:26.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":5885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 15, 2024, reporting person was granted stock appreciation rights (\"SARs\") subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":5885,"derivative":{"exercise_price":48.53,"expiration_date":"2034-09-15","underlying":"Ordinary Shares","underlying_shares":5885},"source":{"system":"sec-edgar","filing":"0001639691-24-000123","document":"wk-form4_1726603520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000123/wk-form4_1726603520.xml","form_type":"4"}},{"id":1405499,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2024-09-17T16:05:26.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (\"TSR\") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's total shareholder return (\"TSR\") for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2575,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001639691-24-000123","document":"wk-form4_1726603520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000123/wk-form4_1726603520.xml","form_type":"4"}},{"id":1405498,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2024-09-17T16:05:26.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":1287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (\"ROIC\") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (\"ROIC\") calculated for the performance period 2024-2026 compares to a target determined by the Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":1287,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1287},"source":{"system":"sec-edgar","filing":"0001639691-24-000123","document":"wk-form4_1726603520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000123/wk-form4_1726603520.xml","form_type":"4"}},{"id":1405497,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Performance Stock Units","published_at":"2024-09-17T16:05:26.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":1287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (\"FCF\") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 15, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (\"FCF\") for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":1287,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1287},"source":{"system":"sec-edgar","filing":"0001639691-24-000123","document":"wk-form4_1726603520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000123/wk-form4_1726603520.xml","form_type":"4"}},{"id":1405496,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54741,"kind":"person","name":"Poletti Franco","position":1,"cik":"0002031281","reported_name":"Poletti Franco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Cardiopulmonary"}}],"security":"Restricted Stock Units","published_at":"2024-09-17T16:05:26.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of LivaNova PLC (the \"Company\"), GBP 1.00 par value, in accordance with the terms of the Company's 2022 Incentive Award Plan (the \"Plan\") and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 15, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on September 15, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":2575,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001639691-24-000123","document":"wk-form4_1726603520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031281/000163969124000123/wk-form4_1726603520.xml","form_type":"4"}}]}